Evidence map›Paper›PMID 21234421›Full record

ArticleExperimental diabetes research2010

Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats.

Murat Olukman, Ebru Demirel Sezer, Sibel Ulker, Eser Y Sözmen, Gülcihan Mehtap Cınar

Open access · hybridAbstract read
In one paragraph

Article in Experimental diabetes research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review article: vascular effects of PPARs in the context of NASH.Alimentary pharmacology & therapeutics · 2022
    Review
  4. Article
  5. Article
  6. Salusin-Oxidative medicine and cellular longevity · 2017
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Pharmacological protection of retinal pigmented epithelial cells by sulindac involves PPAR-α.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Biological evaluation of a siliconized analog of clofibrate (silafibrate) in rodents.Iranian journal of pharmaceutical research : IJPR · 2013
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Murat OlukmanDepartment of Medical Pharmacology, Faculty of Medicine, Ege University, Bornova, 35100 İzmir, Turkey. murat.olukman@ege.edu.tr
Ebru Demirel Sezer
Sibel Ulker
Eser Y Sözmen
Gülcihan Mehtap Cınar
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic endothelial dysfunction is accompanied by increased oxidative stress and upregulated proinflammatory and inflammatory mediators in the vasculature. Activation of peroxisome proliferator-activated receptor-alpha (PPAR-α) results in antioxidant and anti-inflammatory effects. This study was designed to investigate the effect of fenofibrate, a PPAR-α activator, on the endothelial dysfunction, oxidative stress, and inflammation in streptozotocin diabetic rats. Diabetic rats received fenofibrate (150 mg kg(-1) day(-1)) for 4 weeks. Fenofibrate treatment restored the impaired endothelium-dependent relaxation and increased basal nitric oxide availability in diabetic aorta, enhanced erythrocyte/liver superoxide dismutase and catalase levels, ameliorated the abnormal serum/aortic thiobarbituric acid reactive substances, and prevented the increased aortic myeloperoxidase without a significant change in serum total cholesterol and triglyceride levels. It did not affect the decreased total homocysteine level and the increased tumor necrosis factor-α level in the serum of diabetic rats. Fenofibrate-induced prevention of the endothelial function seems to be related to its potential antioxidant and antiinflammatory activity.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsAorta, ThoracicCatalaseDiabetes Mellitus, ExperimentalEndothelium, VascularFenofibrateHypolipidemic AgentsLipidsMaleMuscle ContractionMuscle, Smooth, VascularNitric OxidePeroxidaseRatsAnti-Inflammatory AgentsAntioxidantsCatalaseFenofibrateHypolipidemic AgentsLipidsNitric OxidePeroxidaseSuperoxide DismutaseTumor Necrosis Factor-alpha

Identifiers

PMID21234421
PMCPMC3014714
OpenAlexW2142545529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.